Massachusetts Financial Services’s Bio-Techne TECH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $197M | Sell |
3,733,248
-279,570
| -7% | -$16.8M | 0.07% | 254 |
|
|
2025
Q4 | $236M | Buy |
4,012,818
+2,495,328
| +164% | +$152M | 0.08% | 233 |
|
|
2025
Q3 | $84.4M | Sell |
1,517,490
-138,448
| -8% | -$7.42M | 0.03% | 391 |
|
|
2025
Q2 | $85.2M | Sell |
1,655,938
-1,369,471
| -45% | -$68.8M | 0.03% | 398 |
|
|
2025
Q1 | $177M | Buy |
3,025,409
+472,847
| +19% | +$32M | 0.06% | 295 |
|
|
2024
Q4 | $184M | Sell |
2,552,562
-28,240
| -1% | -$2.07M | 0.06% | 290 |
|
|
2024
Q3 | $206M | Sell |
2,580,802
-8,997
| -0.3% | -$676K | 0.06% | 276 |
|
|
2024
Q2 | $186M | Buy |
2,589,799
+88,257
| +4% | +$6.5M | 0.06% | 276 |
|
|
2024
Q1 | $176M | Buy |
2,501,542
+1,716,999
| +219% | +$123M | 0.05% | 293 |
|
|
2023
Q4 | $60.5M | Buy |
784,543
+731,869
| +1,389% | +$48.2M | 0.02% | 430 |
|
|
2023
Q3 | $3.59M | Sell |
52,674
-132
| -0.2% | -$10.4K | ﹤0.01% | 678 |
|
|
2023
Q2 | $4.31M | Sell |
52,806
-345,134
| -87% | -$27.7M | ﹤0.01% | 655 |
|
|
2023
Q1 | $29.5M | Sell |
397,940
-746,091
| -65% | -$57.5M | 0.01% | 510 |
|
|
2022
Q4 | $94.8M | Sell |
1,144,031
-50,853
| -4% | -$4.04M | 0.03% | 364 |
|
|
2022
Q3 | $84.8M | Sell |
1,194,884
-704,524
| -37% | -$60.9M | 0.03% | 364 |
|
|
2022
Q2 | $165M | Sell |
1,899,408
-285,292
| -13% | -$26.7M | 0.06% | 274 |
|
|
2022
Q1 | $237M | Sell |
2,184,700
-727,440
| -25% | -$75.1M | 0.07% | 239 |
|
|
2021
Q4 | $377M | Sell |
2,912,140
-289,576
| -9% | -$35.5M | 0.1% | 183 |
|
|
2021
Q3 | $388M | Sell |
3,201,716
-28,660
| -0.9% | -$3.49M | 0.11% | 173 |
|
|
2021
Q2 | $364M | Sell |
3,230,376
-388,856
| -11% | -$40.9M | 0.11% | 182 |
|
|
2021
Q1 | $346M | Sell |
3,619,232
-63,356
| -2% | -$5.78M | 0.11% | 179 |
|
|
2020
Q4 | $292M | Buy |
3,682,588
+149,364
| +4% | +$10.8M | 0.09% | 194 |
|
|
2020
Q3 | $219M | Buy |
3,533,224
+114,216
| +3% | +$7.43M | 0.08% | 208 |
|
|
2020
Q2 | $226M | Sell |
3,419,008
-141,488
| -4% | -$8.47M | 0.09% | 196 |
|
|
2020
Q1 | $169M | Buy |
3,560,496
+340,888
| +11% | +$17.1M | 0.08% | 199 |
|
|
2019
Q4 | $177M | Sell |
3,219,608
-585,596
| -15% | -$30.7M | 0.07% | 228 |
|
|
2019
Q3 | $186M | Buy |
3,805,204
+126,800
| +3% | +$6.36M | 0.07% | 212 |
|
|
2019
Q2 | $192M | Buy |
3,678,404
+255,904
| +7% | +$12.9M | 0.08% | 206 |
|
|
2019
Q1 | $170M | Buy |
3,422,500
+207,968
| +6% | +$9.36M | 0.07% | 217 |
|
|
2018
Q4 | $116M | Buy |
3,214,532
+502,660
| +19% | +$21M | 0.06% | 238 |
|
|
2018
Q3 | $138M | Buy |
2,711,872
+319,852
| +13% | +$14.2M | 0.06% | 238 |
|
|
2018
Q2 | $88.5M | Buy |
2,392,020
+539,084
| +29% | +$20.6M | 0.04% | 298 |
|
|
2018
Q1 | $70M | Buy |
1,852,936
+1,502,516
| +429% | +$53.1M | 0.03% | 335 |
|
|
2017
Q4 | $11.3M | Buy |
350,420
+4,616
| +1% | +$147K | ﹤0.01% | 591 |
|
|
2017
Q3 | $10.5M | Sell |
345,804
-51,264
| -13% | -$1.52M | ﹤0.01% | 597 |
|
|
2017
Q2 | $11.7M | Sell |
397,068
-39,480
| -9% | -$1.08M | 0.01% | 579 |
|
|
2017
Q1 | $11.1M | Buy |
436,548
+102,060
| +31% | +$2.63M | 0.01% | 573 |
|
|
2016
Q4 | $8.6M | Buy |
+334,488
| New | +$8.79M | ﹤0.01% | 612 |
|
Other funds holding TECH
VCM
VPM
MC
Massachusetts Financial Services's TECH Position: Q1 2026 in Review
Massachusetts Financial Services reduced its Bio-Techne (TECH) stake by 7% in Q1 2026, selling an estimated $16.8M and leaving 3,733,248 shares worth $197M. The position accounts for 0.07% of the portfolio, ranked #254.
Massachusetts Financial Services first reported a position in TECH in Q4 2016 and has held it in 38 quarters since. The position peaked at $388M in Q3 2021. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.
- Massachusetts Financial Services held 3,733,248 shares of Bio-Techne worth $197M as of Q1 2026.
- Massachusetts Financial Services sold 279,570 Bio-Techne shares in Q1 2026, an estimated $16.8M.
- Bio-Techne made up 0.07% of Massachusetts Financial Services's portfolio in Q1 2026, its #254 holding.
- Massachusetts Financial Services first reported a position in Bio-Techne in Q4 2016 and has held it in 38 quarters since.
- Massachusetts Financial Services's Bio-Techne position peaked at $388M in Q3 2021.
- 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.
Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.